Clinical trial Recruiting at 2 sites Interventional Ages 18 to 50 Women only

Postpartum Mom Power for Opioid Use Disorder

Official title: Postpartum Intervention for Mothers With Opioid Use Disorders (R33)

Run by Stony Brook University · NCT07632053 · Data updated 2026-11-12

This study tests a Mother Power parenting program in moms with opioid use disorder to see if it helps reduce cravings, stress, and improve brain responses to infant cues compared with enhanced usual care.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexWomen only
Enrollment80 (estimated)
SponsorStony Brook University
Academic / other
Locations2 sites (Ann Arbor, Michigan and 1 other locations)
StatusRecruiting
StartedJuly 1, 2025
Main results expectedJuly 2028
Study endsJuly 2028
Registry record updatedJune 9, 2026
Trial IDNCT07632053 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Mothers with opioid use disorder (or on MAT) who have a child aged 5 or younger and can understand English.

Probably not a fit

May not benefit those without MRI compatibility or who do not respond to the intervention components.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two-site randomized trial enrolling about 80 mothers per group to evaluate a maternal postpartum intervention called Mom Power (vMP) for those with opioid use disorder. Participants are assessed before and after the program with behavioral measures and brain imaging to explore changes in maternal brain networks, stress, mood, and cravings. The study compares vMP to enhanced usual care and examines whether brain and behavioral changes mediate any clinical benefits. Eligibility includes OUD diagnosis or MAT, a child aged 5 or younger, and English proficiency; MRI safety criteria apply. The trial is led by Stony Brook University with collaboration from the University of Michigan.

Why it matters

Potential benefit: If successful, the program could reduce maternal stress and cravings and improve mother–child interactions for mothers with OUD.

How similar studies have gone: Prior phases suggested potential brain and behavioral changes with this type of targeted parenting intervention in similar populations, supporting continued testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* mothers with diagnosis of Opioid Use Disorder (OUD); and/or receiving medication assisted treatment (such as buprenorphine or methadone)
* with a child aged 5 or less
* able to read, hear and understand English adequately enough to provide informed consent

Exclusion Criteria:

* require immediate clinical care for suicidal/homicidal risk or psychosis;
* For magnetic resonance imaging (MRI) of the brain, potential participants will be excluded if they: (1) have ferromagnetic metal in their heads (2) have severe claustrophobia that prevents participation in the neuroimaging (3) have serious neurological condition that could interfere with neuroimaging, including a brain tumor, multiple sclerosis or significant head trauma

Where it's running

  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting
  • Stony Brook University
    Stony Brook, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.